이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

가정 기반 호흡 근육 훈련 및 유산소 운동 프로그램이 현 흡연자와 과거 흡연자의 폐 건강을 개선하는 방법

2026년 11월 5일 업데이트: Roswell Park Cancer Institute

호흡근 훈련과 유산소 운동이 흡연자의 폐 건강에 미치는 영향: 폐암 예방을 위한 파일럿 병렬 그룹 연구

This clinical trial studies whether home-based respiratory muscle training (RMT) and aerobic exercise (AE) programs can be used to improve lung health in current and former cigarette smokers. Lung cancer, the leading cause of cancer death, is overwhelmingly caused by exposure to cigarette smoke. Research suggests that daily activity reduces lung cancer risk in current and former smokers. However, current and former smokers are generally not active and new approaches to improve lung health are needed. During the home-based RMT program, participants use a handheld device to complete breathing exercise sessions consisting of breathing in and out against adjustable resistance. During the home-based AE program, participants complete aerobic exercises using a stationary bike working at a moderate workload against adjustable resistance. The home-based RMT and AE programs may be effective ways to strengthen the breathing muscles, which may improve lung health in current and former cigarette smokers.

연구 개요

상세 설명

PRIMARY OBJECTIVES:

I. Evaluate the feasibility of delivering a home-based AE and RMT program in individuals at high risk for lung cancer.

II. Assess the effects of AE and RMT on patient-reported outcomes (PROs), including QoL, fatigue, dyspnea, performance metrics such as respiratory muscle strength and lower extremity strength; the 6-minute walk test; and daily activity levels in high-risk individuals.

III. Investigate whether RMT and/or AE improve peripheral and exhaled biomarkers associated with lung injury, inflammation, and/or oxidative stress.

OUTLINE: Participants scheduled for a computed tomography (CT) scan are assigned to cohort A, participants who call the New York State Quitline (NYSQL) are assigned to cohort B.

COHORT A: Participants are randomized to 1 of 3 arms.

ARM I: Participants complete RMT sessions via the Power Lung device over 20-30 minutes each consisting of three sets of 15 breaths at a gradual increase in resistance, 5 days a week, for 12 weeks in the absence of unacceptable toxicity. Participants also receive a virtually supervised session/call once a week (QW) to provide support, enhance safety, and promote training compliance on study.

ARM II: Participants complete tailored intensity AE cycling sessions progressing to over 30 minutes each, 5 days a week, for 12 weeks in the absence of unacceptable toxicity. Participants also receive a virtually supervised session/call QW to provide support, enhance safety, and promote training compliance on study.

ARM III: Participants receive education on AE and RMT including recommendations aligned with current guidelines 5 days a week for 12 weeks.

COHORT B: Participants are randomized to 1 of 2 arms.

ARM IV: Participants complete RMT sessions as in arm I for 12 weeks in the absence of unacceptable toxicity. Participants also receive a virtually supervised session/call QW to provide support, enhance safety, and promote training compliance on study.

ARM V: Participants receive education on AE and RMT as in arm III on study.

Additionally, all patients undergo blood, nasal swab, exhaled breath, and urine sample collection on study.

After completion of study intervention, participants may be optionally followed up at week 24.

연구 유형

중재적

등록 (추정된)

200

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • New York
      • Buffalo, New York, 미국, 14263
        • Roswell Park Cancer Institute
        • 연락하다:
        • 수석 연구원:
          • Andrew D. Ray

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

50년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

예

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Age ≥ 50 years old
  • Current smoker with a ≥ 20-pack-years history
  • Former smoker within the past 15 years, with a history of ≥ 20 pack-years (CT scan cohort only)
  • Participant must be able to speak, read and comprehend English language
  • Cognitively capable of following direction and performing the intervention
  • Understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure

Exclusion Criteria:

  • Any previous lung cancer diagnoses and or undergoing treatment for any cancer
  • Recent pneumonia, bronchitis, or other inflammatory conditions in the lungs, including but limited to chronic obstructive pulmonary disease (COPD) and/or asthma exacerbation within the previous 6 months
  • Have uncontrolled intercurrent illness including, but not limited to, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, heart failure or psychiatric illness/social situations that would limit compliance with study requirements
  • Unwilling or unable to follow protocol requirements
  • Any condition which in the investigator's opinion deems the participant an unsuitable candidate to receive study intervention

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 방지
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Cohort A Arm I (RMT)

Participants complete RMT sessions via the Power Lung device over 20-30 minutes each consisting of three sets of 15 breaths at a gradual increase in resistance, 5 days a week, for 12 weeks in the absence of unacceptable toxicity. Participants also receive a virtually supervised session/call QW to provide support, enhance safety, and promote training compliance on study. Additionally, patients undergo blood, nasal swab, exhaled breath, and urine sample collection on study.

Ancillary studies

Ancillary studies

Ancillary studies

다른 이름들:
  • 체력 테스트
  • 신체 기능 테스트

Ancillary studies

Undergo blood, nasal swab, exhaled breath, and urine sample collection

다른 이름들:
  • 생물학적 샘플 수집
  • 생체 표본 수집
  • 표본 수집

Complete RMT sessions

다른 이름들:
  • RMT

Receive virtually supervised session/call

다른 이름들:
  • 지지 요법
  • 증상 관리
  • 치료, 지지
실험적: Cohort A Arm II (AE)

Participants complete tailored intensity AE cycling sessions progressing to over 30 minutes each, 5 days a week, for 12 weeks in the absence of unacceptable toxicity. Participants also receive a virtually supervised session/call QW to provide support, enhance safety, and promote training compliance on study. Additionally, patients undergo blood, nasal swab, exhaled breath, and urine sample collection on study.

Ancillary studies

Ancillary studies

Ancillary studies

다른 이름들:
  • 체력 테스트
  • 신체 기능 테스트

Ancillary studies

Undergo blood, nasal swab, exhaled breath, and urine sample collection

다른 이름들:
  • 생물학적 샘플 수집
  • 생체 표본 수집
  • 표본 수집

Receive virtually supervised session/call

다른 이름들:
  • 지지 요법
  • 증상 관리
  • 치료, 지지

Complete tailored intensity AE cycling sessions

다른 이름들:
  • 유산소 활동
활성 비교기: Cohort A Arm III (AE and RMT education)

Participants receive education on AE and RMT including recommendations aligned with current guidelines 5 days a week for 12 weeks. Additionally, patients undergo blood, nasal swab, exhaled breath, and urine sample collection on study.

Ancillary studies

Ancillary studies

Ancillary studies

다른 이름들:
  • 체력 테스트
  • 신체 기능 테스트

Ancillary studies

Undergo blood, nasal swab, exhaled breath, and urine sample collection

다른 이름들:
  • 생물학적 샘플 수집
  • 생체 표본 수집
  • 표본 수집

Receive AE and RMT education

다른 이름들:
  • 중재 교육
  • 교육에 의한 개입
  • 교육을 통한 개입
  • 개입, 교육
실험적: Cohort B Arm IV (RMT)

Participants complete RMT sessions as in arm I for 12 weeks in the absence of unacceptable toxicity. Participants also receive a virtually supervised session/call QW to provide support, enhance safety, and promote training compliance on study. Additionally, patients undergo blood, nasal swab, exhaled breath, and urine sample collection on study.

Ancillary studies

Ancillary studies

다른 이름들:
  • 체력 테스트
  • 신체 기능 테스트

Ancillary studies

Undergo blood, nasal swab, exhaled breath, and urine sample collection

다른 이름들:
  • 생물학적 샘플 수집
  • 생체 표본 수집
  • 표본 수집

Complete RMT sessions

다른 이름들:
  • RMT

Receive virtually supervised session/call

다른 이름들:
  • 지지 요법
  • 증상 관리
  • 치료, 지지
활성 비교기: Cohort B Arm V (AE and RMT education)

Participants receive education on AE and RMT as in arm III on study. Additionally, patients undergo blood, nasal swab, exhaled breath, and urine sample collection on study.

Ancillary studies

Ancillary studies

다른 이름들:
  • 체력 테스트
  • 신체 기능 테스트

Ancillary studies

Undergo blood, nasal swab, exhaled breath, and urine sample collection

다른 이름들:
  • 생물학적 샘플 수집
  • 생체 표본 수집
  • 표본 수집

Receive AE and RMT education

다른 이름들:
  • 중재 교육
  • 교육에 의한 개입
  • 교육을 통한 개입
  • 개입, 교육

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Compliance rate (Feasibility)
기간: Up to 12 weeks

The primary objective is in the feasibility of conducting the respiratory muscle training (RMT) and aerobic exercise (AE) intervention relative to the sham control. In the RMT group, overall compliance (e.g., compliant at all time points) will be estimated using 90% confidence intervals (CIs) obtained Clopper-Pearson method. The lower bounds will define a plausible lower limit for true (unobserved) compliance rates. Additionally, compliance status will be modeled as a function of time (e.g., week), and pre-specified exogenous factors using a generalized estimating equation logistic regression model (autoregressive covariance structure). Estimates of compliance rates will be obtained by time-point and tests about the appropriate contrasts of model estimates will be used to determine if there is a time trend.

Up to 12 weeks
Adherence rate (Feasibility)
기간: Up to 12 weeks

The primary objective is in the feasibility of conducting the RMT and AE intervention relative to the sham control. In the RMT group, overall adherence (complete ≥ 70% of sessions) rates will be estimated using 90% CIs obtained Clopper-Pearson method. The lower bounds will define a plausible lower limit for true (unobserved) adherence rates.

Up to 12 weeks
Assessing inspiratory and expiratory muscle strength
기간: At baseline, 6 weeks, and 12 weeks

Participants will complete 3 sets of 15 breaths, 5 days/week using commercially available Power Lung. resistance will be increased 5-10% every week . Participants will rate and log their effort

At baseline, 6 weeks, and 12 weeks
change in St. George Respiratory Questionnaire (SGRQ)
기간: At baseline, 6 weeks, and 12 weeks

The SGRQ comprises of 50 items and consists of two parts. Scores range from 0-100, with higher scores indicating worse quality of life.

At baseline, 6 weeks, and 12 weeks
Functional capacity
기간: At baseline, 6 weeks, and 12 weeks

Measured by the 6-Minute Walk Test. Will be summarized at pre-, 6-week and post-intervention timepoints, regardless of treatment regimen, using the appropriate descriptive statistics and graphically summarized. The outcome will be analyzed using a linear mixed model, with the intervention arms and time points as predictors. Baseline measurements will be included as a covariate to adjust for initial differences. Both within-and between-group comparisons will be conducted using appropriate contrasts. The primary comparisons will focus on between-arm differences at the 12-week post-intervention time point. Comparisons at the 6-week and 3-month follow-up visits will be secondary and will only be performed if the primary comparison for the corresponding endpoint reaches statistical significance. For cohort A, Bonferroni's correction will be applied to adjust for three pairwise comparisons.

At baseline, 6 weeks, and 12 weeks

2차 결과 측정

결과 측정
측정값 설명
기간
Lower extremity strength
기간: At baseline and 12 weeks

Measured using the 30-Second Sit-to-Stand Test. The outcome will be analyzed using a linear mixed model, with the intervention arms and time points as predictors. Baseline measurements will be included as a covariate to adjust for initial differences. Both within-and between-group comparisons will be conducted using appropriate contrasts. The primary comparisons will focus on between-arm differences at the 12-week post-intervention time point.

At baseline and 12 weeks
Physical performance
기간: At baseline and 12 weeks

Measured using the Short Physical Performance Battery. The outcome will be analyzed using a linear mixed model, with the intervention arms and time points as predictors. Baseline measurements will be included as a covariate to adjust for initial differences. Both within-and between-group comparisons will be conducted using appropriate contrasts. The primary comparisons will focus on between-arm differences at the 12-week post-intervention time point.

At baseline and 12 weeks
Physical activity levels
기간: Up to 12 weeks

daily step counts and minutes at various intensity levels will be monitored with an activity tracker. Both within-and between-group comparisons will be conducted using appropriate contrasts. The primary comparisons will focus on between-arm differences at the 12-week post-intervention time point.

Up to 12 weeks
Patient-reported outcomes on Fatigue
기간: At baseline and 12 weeks

he Functional Assessment of Chronic Illness Therapy (FACIT- fatigue scale) is a 13-item patient-reported measure of fatigue. Items are scored on a 0 - 4 response scale with anchors ranging from "Not at all" to "Very much so". To score the FACIT-fatigue, all items are summed to create a single fatigue score with a range from 0 to 52. The higher the score, the lower the score the greater the fatigue severity

At baseline and 12 weeks
High-sensitivity C-reactive protein
기간: At baseline and 12 weeks

The outcome will be analyzed using a linear mixed model, with the intervention arms and time points as predictors. Baseline measurements will be included as a covariate to adjust for initial differences. Both within-and between-group comparisons will be conducted using appropriate contrasts. The primary comparisons will focus on between-arm differences at the 12-week post-intervention time point.

At baseline and 12 weeks
Cardiac biomarkers
기간: At baseline and at 12 weeks

Will assess cardiac biomarkers, such as high-sensitivity troponin T and N-terminal pro-brain natriuretic peptide. The outcome will be analyzed using a linear mixed model, with the intervention arms and time points as predictors. Baseline measurements will be included as a covariate to adjust for initial differences. Both within-and between-group comparisons will be conducted using appropriate contrasts. The primary comparisons will focus on between-arm differences at the 12-week post-intervention time point. Biomarker data will be appropriately transformed prior to analysis to meet model assumptions.

At baseline and at 12 weeks
Dyspnea patient reported response
기간: Baseline and at 12 weeks

he Dyspnea-12 describes the different qualitative dimensions of breathlessness. Each 12- item (seven for the physical and five for the affective components) score ranges from 'none' (score 0) to 'severe' (score 3) with a total score ranging from 0 to 36 (lower is better), a physical score ranging from 0 to 21 and an affective score ranging from 0 to 15

Baseline and at 12 weeks

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Andrew D Ray, Roswell Park Cancer Institute

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 12월 15일

기본 완료 (추정된)

2029년 5월 1일

연구 완료 (추정된)

2029년 5월 1일

연구 등록 날짜

최초 제출

2026년 4월 1일

QC 기준을 충족하는 최초 제출

2026년 4월 20일

처음 게시됨 (실제)

2026년 4월 28일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 6일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 5일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다